Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

On Thursday 19 April, Oxford University will play host to an AIMday focused on Biomedical Imaging, which is at the heart of much of the clinical and biomedical research conducted at the University.

Following successful AIMdays focusing on Microscopy and Ageing, in April the Divisional Business Development Team will be running an AIMday in Biomedical Imaging, a broad topic which offers the opportunity to discuss the analysis, enhancement and display of images captured via x-ray, ultrasound, MRI, nuclear medicine and optical imaging technologies. A range of companies including GSK, GE Healthcare, Siemens, and Blue Earth Diagnostics are registered to attend, and it is a fantastic chance for researchers looking to network with industry and discuss relevant questions.

AIMdays are a concept which offer a unique way to facilitate interaction between industry and academia. Born at the University of Uppsala in 2008, they have increasingly gathered attention and use at universities across the globe looking to match researchers with industrial partners.

Interested industry partners are invited to submit questions around a certain topic. At the Microscopy AIMday run in Oxford last year, companies including Zeiss, Olympus, and Andor Technology submitted questions around imaging technologies to aid medical diagnostics, use of virtual reality to understand biological processes, and novel techniques for the future of microscopy research.

Academics then choose which of these questions they would like to answer, depending on their particular area of expertise. The AIMday algorithm designs a programme of one-hour sessions that matches industry partners and academics by their shared interests so that sessions can run in parallel, and interaction between industry and academics is maximised. 

Martin Kerr, Business Development Manager and organiser of the AIMday commented: 'AIMdays are a fantastic opportunity for researchers to spark new collaborations, build their networks, and get a fresh perspective on how their work could be translatable. It also offers early stage researchers exposure to the career paths offered by industry.' 

AIMday Biomedical Imaging takes place on Thu 19 April.  Academic registration opens on Mon 26 Feb – find out more and register.

If you would like to find out more about running an AIMday, please contact Martin Kerr

Similar stories

AIMday in Women's Health - registration for academics now open

Events Innovation

Are you an academic interested in finding out how your knowledge can be used to solve industry challenges? Would you like to widen your network? Meet potential collaborators / future employees? Gain insights into relevant funding schemes? If you answer YES to any of the above, now is the time to register for the AIMday in Women's Health.

Innovation award for Professor Anindita Roy to develop new treatments for childhood cancer

Awards and Appointments General Innovation Research

Associate Professor Andi Roy leads one of the five research teams across the UK that have been awarded the 2021 Cancer Research UK-Children with Cancer UK Innovation Award. The awards, which provide a total of £4.3 million in scientific funding, will allow leading researchers in the field to delve into the biology of children’s and young people’s cancers, with the hope of finding new ways to prevent and treat these complex cancers.

Association of Physicians of Great Britain and Ireland Annual Meeting opens to wider medical community for first time in over a century

Events General

Established in 1907, the Association of Physicians of Great Britain and Ireland (AoPGBI) has traditionally only invited the highest-profile doctors and researchers to its annual meeting. Now, they have made the landmark decision to open their (virtual) doors to the wider medical community, primarily to clinicians, early career researchers, discovery scientists and industry affiliates.

Oxford vaccine creator Professor Sarah Gilbert awarded RSA Albert Medal

Awards and Appointments Coronavirus COVID-19 General Innovation Research

Professor Sarah Gilbert has been awarded the Royal Society for Arts, Manufactures and Commerce’ (RSA) Albert Medal for her work on the Oxford vaccine.

Singula Bio, a new Oxford spin-out company - Cancer need not be fatal

General Innovation Research

Singula Bio, a bold new seed-stage biotechnology company spun out of Oxford University, has been launched with the intention of helping show that cancer need not be fatal. Led by three Oxford cancer specialists, the firm is aims to become a world leader in therapies to use against difficult-to-treat solid malignancies such as ovarian cancer - using the body’s own immune system to fight previously fatal cancers.

Oxford to collaborate with Janssen to map the cellular landscape of immune mediated disorders

General Innovation

The University of Oxford announced today that it has entered into a strategic collaboration with Janssen Biotech, Inc., one of the Janssen Pharmaceutical Companies of Johnson & Johnson.